SCHEMBL375694

SCHEMBL375694

CC(=O)C(CC(=O)c1ccccc1)C(=O)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
KMT2A Q03164 4/20 0.51
TDP1 Q9NUW8 2/20 0.51
SLC6A2 P23975 1/20 0.51
SLC6A3 Q01959 1/20 0.51
MEN1 O00255 1/20 0.49
NPC1 O15118 1/20 0.49
ELANE P08246 1/20 0.45
TSHR P16473 1/20 0.45
LMNA P02545 2/20 0.44
RAB9A P51151 1/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
MAPK1 P28482 1/20 0.44
POLB P06746 1/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MAOB P27338 2/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
CTSB P07858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3031863 0.90 L3MBTL1 (0.50) ALDH1A1KMT2ATDP1SLC6A2SLC6A3
SCHEMBL10415038 0.86 ALDH1A1 (0.58) ALDH1A1KMT2ATDP1SLC6A2SLC6A3
SCHEMBL1156528 0.84 KMT2A (0.69) ALDH1A1KMT2ATDP1MEN1NPC1
SCHEMBL8535189 0.83 KMT2A (0.68) ALDH1A1KMT2ATDP1MEN1NPC1
SCHEMBL3822474 0.82 L3MBTL1 (0.58) ALDH1A1KMT2AMEN1NPC1LMNA
SCHEMBL26757664 0.81 ALDH1A1 (0.59) ALDH1A1KMT2ATDP1SLC6A2SLC6A3
SCHEMBL22507577 0.81 ALDH1A1 (0.59) ALDH1A1KMT2ATDP1SLC6A2SLC6A3
SCHEMBL7434246 0.81 ALDH1A1 (0.59) ALDH1A1KMT2ATDP1SLC6A2SLC6A3
SCHEMBL10708405 0.81 ALDH1A1 (0.59) ALDH1A1KMT2ATDP1SLC6A2SLC6A3
SCHEMBL15441486 0.81 ALDH1A1 (0.51) ALDH1A1KMT2ATDP1SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8754252-B2 Asymmetric cyclization processes using unsaturated nitro compounds NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2014-06-17 US disclosed
US-20130096338-A1 ASYMMETRIC CYCLIZATION PROCESSES USING UNSATURATED NITRO COMPOUNDS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2013-04-18 US disclosed
US-8222274-B2 Pyrrole derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2012-07-17 US disclosed
EP-1988075-B1 PYRROLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC (JP) 2012-01-25 EP disclosed
US-20100298576-A1 ASYMMETRIC CYCLIZATION PROCESSES USING UNSATURATED NITRO COMPOUNDS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2010-11-25 US disclosed
US-20090036421-A1 Pyrrole Derivative or Salt Thereof ASTELLAS PHARMA INC (JP) 2009-02-05 US disclosed
EP-1988075-A1 PYRROLE DERIVATIVE OR SALT THEREOF Astellas Pharma Inc. (JP) 2008-11-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036421-A1 Pyrrole Derivative or Salt Thereof HTR7, HTR2B, SSTR5 ALDH1A1 4209/4885KMT2A 4232/4885TDP1 3645/4885
US-20130096338-A1 ASYMMETRIC CYCLIZATION PROCESSES USING UNSATURATED NITRO COMPOUNDS NQO1, COASY, NOS2 ALDH1A1 2383/4885KMT2A 3541/4885TDP1 3674/4885
US-20100298576-A1 ASYMMETRIC CYCLIZATION PROCESSES USING UNSATURATED NITRO COMPOUNDS NQO1, COASY, NOS2 ALDH1A1 2383/4885KMT2A 3541/4885TDP1 3674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.